2,062 results on '"TREBICKA, JONEL"'
Search Results
2. A robust clustering strategy for stratification unveils unique patient subgroups in acutely decompensated cirrhosis
3. Alterations of the peptidomic composition of peripheral plasma after portal hypertension correction by transjugular intrahepatic portosystemic shunt
4. Comparative analysis of SEC61A1 mutant R236C in two patient-derived cellular platforms
5. Imaging-based diagnosis of sarcopenia for transplant-free survival in primary sclerosing cholangitis
6. Radiomics-Based Prediction Model for Outcome of Radioembolization in Metastatic Colorectal Cancer
7. Association between endotoxemia and blood no in the portal circulation of cirrhotic patients: results of a pilot study
8. Safety, efficacy, and survival of different transarterial chemoembolization techniques in the management of unresectable hepatocellular carcinoma: a comparative single-center analysis
9. Palmitoylcarnitine impairs immunity in decompensated cirrhosis
10. Albumin reprograms the B cell transcriptional landscape and improves neutrophil antimicrobial function in patients with decompensated cirrhosis
11. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD
12. The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases
13. Non-invasive Assessment of Clinically Significant Portal Hypertension
14. Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases
15. Stage of fibrosis is not a predictive determinant of weight loss in patients undergoing bariatric surgery
16. Role of endoscopy in hepatology
17. Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease
18. Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV
19. The rationale and study design of two phase II trials examining the effects of BI 685,509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis
20. Health-related quality of life outcomes following Roux-en-Y gastric bypass versus one anastomosis gastric bypass
21. Das akut-auf-chronische Leberversagen
22. Closing spontaneous portosystemic shunts in cirrhosis: Does it make sense? Does it work? What does it take?
23. Soluble urokinase plasminogen activator receptor levels predict survival in patients with portal hypertension undergoing TIPS
24. Infections increase the risk of decompensation and death in patients with early alcohol-related liver disease
25. Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis
26. Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome
27. Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake
28. Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study
29. Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding
30. Endoscopic procedures in hepatology: Current trends and new developments
31. MELD-Lactate Predicts Poor Outcome in Variceal Bleeding in Cirrhosis
32. Blood Endotoxin Levels as Biomarker of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
33. Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure
34. Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America
35. A Long-Term Comparative Study Between One Anastomosis Gastric Bypass and Sleeve Gastrectomy
36. Myostatin is associated with the presence and development of acute-on-chronic liver failure
37. EASL Clinical Practice Guidelines on acute-on-chronic liver failure
38. Interferon-induced IL-10 drives systemic T-cell dysfunction during chronic liver injury
39. Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial
40. Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis
41. Alox12/15 Deficiency Exacerbates, While Lipoxin A4 Ameliorates Hepatic Inflammation in Murine Alcoholic Hepatitis
42. Evaluation of the In Vitro and In Vivo Effects of Biglycan in Innate Immunity
43. Results of the Baveno VII Questionnaire on the 'Impact of Non-etiological Therapies in the Course of Cirrhosis'
44. Statins in Compensated and Decompensated Cirrhosis: Approaching the Bedside
45. Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis
46. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis
47. THU-083 Acute kidney injury (AKI) severity in critically-ill patients with decompensated liver cirrhosis and acute-on-chronic liver failure (ACLF)
48. WED-074 The role of endothelial FoxO1 pathway in decompensated liver cirrhosis and acute-on-chronic liver failure
49. WED-078 Systemic albumin administration improves the gut microbiome and intestinal permeability in animal models of cirrhosis and ACLF
50. THU-088 Blood and peritoneal metabolomics suggest VS-01 actively captures metabolites associated with acute-on-chronic liver failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.